<DOC>
	<DOCNO>NCT01310647</DOCNO>
	<brief_summary>The aim study compare effectiveness testosterone , estradiol combine treatment estrogens/progestagens prior IVF-ICSI previously diagnose low responder patient .</brief_summary>
	<brief_title>Antral Follicle Priming Prior ICSI ( Intracytoplasmic Sperm Injection ) Previously Diagnosed Low Responders</brief_title>
	<detailed_description>During control ovarian hyperstimulation ( COH ) , early antral follicle require grow coordinately . Marked follicular size discrepancy COH imply important number follicle undergo unsatisfactory maturation . It prove follicular prim estradiol luteal phase cycle prior COH testosterone treatment early follicular phase COH cycle may increase amount oocyte embryos retrieve . Nevertheless prospective study compare approach . The present study consist two phase : The present study consist two different phase : - Phase I : ( Non randomize ) Identification confirm low responder patient . Potential low responder patient subject standardized ovarian hyperstimulation protocol - Phase II : ( Randomized ) patient , confirm low responder , offer opportunity enter interventional part study , randomize three different treatment group : estradiol , testosterone combine progestagens estrogens prior IVF-ICSI cycle . The previous cycle ( phase I ) use self-control patient .</detailed_description>
	<mesh_term>Ovarian Diseases</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>1 . Phase 1 ( Non randomize . The patient must fit first plus least 2 criterion ) Infertility require IVF/ICSI treatment Age ≥ 38 year Basal FSH ≥ 10 mUI/ml ( day 3 cycle ) Serum AMH ≤ 5 pmol/l Antral follicular count ≤ 6 ( day 3 cycle ) 2 . Phase 2 ( Randomized . The patient must fit least one criterion regard day GNRH analogue administration cycle perform Phase 1 ) Less 4 follicle mean diameter measure 16mm Serum estradiol level ≤ 500 pg/ml 4 MII less 4 MII oocyte retrieve Patients suffer endometriosis Patients progesterone level ≤ 4 ng/ml ( day 21 cycle ) Patients partner affect severe oligo/astheno/teratozoospermia</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>41 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>estradiol</keyword>
	<keyword>testosterone</keyword>
	<keyword>combine oral contraceptive</keyword>
	<keyword>low responder</keyword>
	<keyword>ICSI</keyword>
</DOC>